Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $1.20 billion. The enterprise value is $1.82 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.82B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 156.53 million shares outstanding. The number of shares has decreased by -16.57% in one year.
| Shares Outstanding | 156.53M |
| Shares Change (YoY) | -16.57% |
| Shares Change (QoQ) | -16.52% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 108.80% |
| Float | 137.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.65 |
| PS Ratio | 2.70 |
| Forward PS | 2.62 |
| PB Ratio | n/a |
| P/FCF Ratio | 6.54 |
| PEG Ratio | -0.26 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 9.94 |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.91 |
| Interest Coverage | -41.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -145.60% |
| Return on Capital (ROIC) | -256.05% |
| Revenue Per Employee | $1.66M |
| Profits Per Employee | -$3.75M |
| Employee Count | 267 |
| Asset Turnover | 0.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $83.49 million in taxes.
| Income Tax | 83.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.88% in the last 52 weeks. The beta is 0.55, so IRWD's price volatility has been lower than the market average.
| Beta (1Y) | 0.55 |
| 52-Week Price Change | -31.88% |
| 50-Day Moving Average | 10.63 |
| 200-Day Moving Average | 10.43 |
| Relative Strength Index (RSI) | 27.84 |
| Average Volume (30 Days) | 4,700,719 |
Short Selling Information
The latest short interest is 21.95 million, so 14.03% of the outstanding shares have been sold short.
| Short Interest | 21.95M |
| Short Previous Month | 18.77M |
| Short % of Shares Out | 14.03% |
| Short % of Float | 16.02% |
| Short Ratio (days to cover) | 2.87 |
Income Statement
In the last 12 months, IRWD had revenue of $442.74 million and -$1.00 billion in losses. Loss per share was -$6.45.
| Revenue | 442.74M |
| Gross Profit | 442.74M |
| Operating Income | -945.43M |
| Pretax Income | -918.75M |
| Net Income | -1.00B |
| EBITDA | -895.55M |
| EBIT | -897.12M |
| Loss Per Share | -$6.45 |
Balance Sheet
The company has $92.15 million in cash and $715.54 million in debt, giving a net cash position of -$623.38 million or -$3.98 per share.
| Cash & Cash Equivalents | 92.15M |
| Total Debt | 715.54M |
| Net Cash | -623.38M |
| Net Cash Per Share | -$3.98 |
| Equity / Book Value | -346.30M |
| Book Value Per Share | -2.21 |
| Working Capital | -42.81M |
Cash Flow
In the last 12 months, operating cash flow was $183.43 million and capital expenditures -$273,000, giving a free cash flow of $183.15 million.
| Operating Cash Flow | 183.43M |
| Capital Expenditures | -273,000 |
| Free Cash Flow | 183.15M |
| FCF Per Share | $1.18 |
Margins
Gross margin is 100.00%, with operating and profit margins of -213.54% and -226.37%.
| Gross Margin | 100.00% |
| Operating Margin | -213.54% |
| Pretax Margin | -207.52% |
| Profit Margin | -226.37% |
| EBITDA Margin | -202.28% |
| EBIT Margin | -202.63% |
| FCF Margin | 41.37% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 16.57% |
| Shareholder Yield | 16.57% |
| Earnings Yield | -83.70% |
| FCF Yield | 15.30% |
Analyst Forecast
The average price target for IRWD is $19.50, which is 154.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.50 |
| Price Target Difference | 154.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 22.69% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 2, 2019. It was a forward split with a ratio of 1194:1000.
| Last Split Date | Apr 2, 2019 |
| Split Type | Forward |
| Split Ratio | 1194:1000 |
Scores
IRWD has an Altman Z-Score of -9.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.62 |
| Piotroski F-Score | 3 |